Healthcare Global Enterprises · NSE: HCG · BSE: 539787

Q4 FY26 results · Jan–Mar 2026

Healthcare Global Enterprises reported revenue from operations of ₹652.33 crore (up 11.5% from Q4 FY25) and net profit of ₹4.04 crore (down 40.3% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY26	Q4 FY25	YoY	Q3 FY26	QoQ
Revenue from operations	652.33	585.16	+11.5%	633.07	+3.0%
Other income	13.07	10.23	+27.8%	2.47	+429.1%
Total income	665.40	595.39	+11.8%	635.54	+4.7%
Profit before share of associates & JVs and tax	0.73	13.71	−94.7%	(6.02)	Turned profit
Share of profit/(loss) of associates & JVs	0.52	(0.09)		(0.05)
Net profit for the period	4.04	6.77	−40.3%	(7.90)	Turned profit
Attributable to shareholders of the company	2.17	7.36	−70.5%	(9.43)	Turned profit
EPS, basic (₹)	0.15	0.53	−71.7%	(0.68)	Turned profit
Net margin (%)	0.6	1.2		-1.2

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q4 FY26	Q4 FY25	YoY	Q3 FY26	QoQ
Revenue from operations	350.21	324.39	+8.0%	342.16	+2.4%
Other income	14.92	9.46	+57.7%	2.99	+399.0%
Total income	365.13	333.85	+9.4%	345.15	+5.8%
Profit before tax	(8.95)	16.81	Turned loss	(1.27)	Loss widened
Net profit for the period	1.53	10.16	−84.9%	(1.18)	Turned profit
EPS, basic (₹)	0.11	0.73	−84.9%	(0.08)	Turned profit
Net margin (%)	0.4	3.1		-0.3

Consolidated

Filed with BSE: 19 May 2026, 23:51 IST
Board meeting: 19 May 2026
Period: 01 Jan 2026 to 31 Mar 2026
Review status: Audited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 19 May 2026, 23:51 IST
Board meeting: 19 May 2026
Period: 01 Jan 2026 to 31 Mar 2026
Review status: Audited
Source: XBRL filing on BSE